Literature DB >> 16533539

Does Down's syndrome support the homocysteine theory of atherogenesis? Experience in elderly subjects with trisomy 21.

Federico Licastro1, Alessandro Marocchi, Silvana Penco, Elisa Porcellini, Domenico Lio, Giada Dogliotti, Massimiliano M Corsi.   

Abstract

Down syndrome (DS) is generally considered as an "atheroma-free model". In this preliminary study, we investigated homocysteine, folate and Vitamin B(12) levels in 13 DS patients (male, average age 60 years) and 20 age-matched individuals. We also studied lipid fractions, and polymorphisms for Cystothionine beta-synthase (CBS), 5,10-methyl-tetrahydro-folate reductase (MTHFR) and apolipoprotein E (Apo-E) genes. However, DS patients with the MTHFR TT genotype showed an increased of plasma homocysteine (tHcy). Our results indicate that this group of "healthy old" Down syndrome patients, although showing some classical biochemical risk factors for atherosclerosis, did not suffer clinical cardiovascular alterations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16533539     DOI: 10.1016/j.archger.2006.01.003

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  17 in total

1.  Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins.

Authors:  Terry S Elton; Sarah E Sansom; Mickey M Martin
Journal:  RNA Biol       Date:  2010-09-01       Impact factor: 4.652

Review 2.  Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.

Authors:  Donna M Wilcock; Frederick A Schmitt; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2015-11-26

3.  Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP.

Authors:  Eric Doran; David Keator; Elizabeth Head; Michael J Phelan; Ron Kim; Minodora Totoiu; Jorge R Barrio; Gary W Small; Steven G Potkin; Ira T Lott
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 4.  Cobalamin C defect: natural history, pathophysiology, and treatment.

Authors:  Diego Martinelli; Federica Deodato; Carlo Dionisi-Vici
Journal:  J Inherit Metab Dis       Date:  2010-07-15       Impact factor: 4.982

5.  DHFR 19-bp deletion and SHMT C1420T polymorphisms and metabolite concentrations of the folate pathway in individuals with Down syndrome.

Authors:  Cristiani Cortez Mendes; Aline Maria Zanchetta de Aquino Raimundo; Luciana Dutra Oliveira; Bruna Lancia Zampieri; Gustavo Henrique Marucci; Joice Matos Biselli; Eny Maria Goloni-Bertollo; Marcos Nogueira Eberlin; Renato Haddad; Maria Francesca Riccio; Hélio Vannucchi; Valdemir Melechco Carvalho; Érika Cristina Pavarino
Journal:  Genet Test Mol Biomarkers       Date:  2013-02-19

6.  Genetic polymorphisms modulate the folate metabolism of Brazilian individuals with Down syndrome.

Authors:  J M Biselli; B L Zampieri; E M Goloni-Bertollo; R Haddad; M F R Fonseca; M N Eberlin; H Vannucchi; V M Carvalho; E C Pavarino
Journal:  Mol Biol Rep       Date:  2012-08-19       Impact factor: 2.316

7.  DYRK1A, a novel determinant of the methionine-homocysteine cycle in different mouse models overexpressing this Down-syndrome-associated kinase.

Authors:  Christophe Noll; Chris Planque; Clémentine Ripoll; Fayçal Guedj; Anna Diez; Véronique Ducros; Nicole Belin; Arnaud Duchon; Jean-Louis Paul; Anne Badel; Bénédicte de Freminville; Yann Grattau; Henri Bléhaut; Yann Herault; Nathalie Janel; Jean-Maurice Delabar
Journal:  PLoS One       Date:  2009-10-21       Impact factor: 3.240

8.  Cardiovascular Disease, Single Nucleotide Polymorphisms; and the Renin Angiotensin System: Is There a MicroRNA Connection?

Authors:  Terry S Elton; Sarah E Sansom; Mickey M Martin
Journal:  Int J Hypertens       Date:  2010-08-04       Impact factor: 2.420

9.  A functional variant in the cystathionine β-synthase gene promoter significantly reduces congenital heart disease susceptibility in a Han Chinese population.

Authors:  Jian-Yuan Zhao; Xue-Yan Yang; Kai-Hu Shi; Shu-Na Sun; Jia Hou; Zhi-Zhou Ye; Jue Wang; Wen-Yuan Duan; Bin Qiao; Yi-Jiang Chen; Hong-Bing Shen; Guo-Ying Huang; Li Jin; Hong-Yan Wang
Journal:  Cell Res       Date:  2012-09-18       Impact factor: 25.617

Review 10.  Peripheral Oxidation Markers in Down Syndrome Patients: The Better and the Worse.

Authors:  Dominik Szwajgier; Ewa Baranowska-Wójcik; Joanna Grzelczyk; Wioletta Żukiewicz-Sobczak
Journal:  Dis Markers       Date:  2021-06-28       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.